ONI Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 155
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $75M
Latest Deal Amount
  • Investors
  • 16

ONI General Information

Description

Developer of high-resolution microscopes designed to enhance biological research work. The company's microscopes are capable of zooming in on structures within living cells to provide a different level of usability and precision for researchers, enabling healthcare professionals to focus on the research work which was previously inaccessible and assist them to understand cells and combat disease at the molecular level.

Contact Information

Website
www.oni.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Other Healthcare Technology Systems
Primary Office
  • Linacre House
  • Banbury Road
  • Oxford OX2 8TA
  • England, United Kingdom
+44 01865 000000

ONI Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ONI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 20-Jan-2022 $75M 00000 Completed Generating Revenue/Not Profitable
5. Grant 01-Oct-2020 00000 000.00 Completed Generating Revenue/Not Profitable
4. Early Stage VC 10-Jul-2020 00.000 000.00 00000 Completed Generating Revenue/Not Profitable
3. Early Stage VC (Series A) 13-Jul-2018 0000 0000 000.00 Completed Generating Revenue/Not Profitable
2. Seed Round 15-Aug-2017 $4.24M $5.97M 000.00 Completed Generating Revenue/Not Profitable
1. Seed Round 10-May-2016 $1.73M $1.73M 00.000 Completed Startup
To view ONI’s complete valuation and funding history, request access »

ONI Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 00000.00 00000.00 00 00000.00 0.000
Series A 000,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 52,000 $0.012476 $77.97 $77.97 1x $77.97 21.94%
Ordinary 60,000 $0.012476 $24.95 $24.95 1x $24.95 25.32%
To view ONI’s complete cap table history, request access »

ONI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of high-resolution microscopes designed to enhance biological research work. The company's microscopes are cap
Discovery Tools (Healthcare)
Oxford, United Kingdom
155 As of 2022
00000
00000000000 00000

00000000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000000000000
Paris, France
0 As of 0000
000000000000

00000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ulla
0000000000 000000000
Boston, MA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ONI Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbelight Accelerator/Incubator Backed Paris, France 0 000000000000
00000000 000000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
00000000 000000 Formerly VC-backed Emeryville, CA 000 00000 00000000 00000
00000 000000000000 Formerly PE-Backed Wetzlar, Germany 0000 000000&0
00000000 000000000 Corporation Jupiter, FL
To view ONI’s complete competitors history, request access »

ONI Patents

ONI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2595520-A A diagnostic device and method Pending 29-May-2020 00000000000 0
GB-2588627-A An optical imaging system Pending 29-Oct-2019 00000000000
GB-201915679-D0 An optical imaging system Pending 29-Oct-2019 00000000000
GB-201807409-D0 Assay Ceased 04-May-2018 0000000000
EP-3788374-A1 Imaging assays Pending 04-May-2018 G01N33/54353
To view ONI’s complete patent history, request access »

ONI Executive Team (6)

Name Title Board Seat Contact Info
Bo Jing Ph.D Co-Founder, Board Member & Chief Executive Officer
Sophia Mowla Chief Growth Officer and Board Advisor
Tyler Ralston Ph.D Chief Technology Officer
You’re viewing 3 of 6 executive team members. Get the full list »

ONI Board Members (13)

Name Representing Role Since
Alexis Dormandy Oxford Science Enterprises Board Member 000 0000
Bo Jing Ph.D ONI Co-Founder, Board Member & Chief Executive Officer 000 0000
Keith Craig ONI Board Member 000 0000
Keith Crandell ARCH Venture Partners Board Member 000 0000
Mark Evans Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

ONI Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ONI Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
ARTIS Ventures Venture Capital Minority 000 0000 000000 0
Axon Ventures Venture Capital Minority 000 0000 000000 0
Paul Conley Angel (individual) Minority 000 0000 000000 0
Section 32 Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »